Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Proteome Res ; 17(7): 2421-2427, 2018 07 06.
Artículo en Inglés | MEDLINE | ID: mdl-29877085

RESUMEN

The vitreous humor is a highly aqueous eye fluid interfacing with the retina and lens and providing shape. Its molecular composition provides a readout for the eye's physiological status. Changes in cellular metabolism underlie vitreoretinal pathologies, but despite routine surgical collection of vitreous, only limited reports of metabolism in the vitreous of human patients have been described. Vitreous samples from patients with rhegmatogenous retinal detachment ( n = 25) and proliferative diabetic retinopathy ( n = 9) were profiled along with control human vitreous samples ( n = 8) by untargeted mass-spectrometry-based metabolomics. Profound changes were observed in diabetic retinopathy vitreous, including altered glucose metabolism and activation of the pentose phosphate pathway, which provides reducing equivalents to counter oxidative stress. In addition, purine metabolism was altered in diabetic retinopathy, with decreased xanthine and elevated levels of related purines (inosine, hypoxanthine, urate, allantoate) generated in oxidant-producing reactions. In contrast, the vitreous metabolite profiles of retinal detachment patients were similar to controls. In total, our results suggest a rewiring of vitreous metabolism in diabetic retinopathy that underlies disease features such as oxidative stress and furthermore illustrates how the vitreous metabolic profile may be impacted by disease.


Asunto(s)
Retinopatía Diabética/metabolismo , Enfermedades Hereditarias del Ojo/metabolismo , Metabolómica/métodos , Desprendimiento de Retina/metabolismo , Cuerpo Vítreo/metabolismo , Glucosa/metabolismo , Humanos , Espectrometría de Masas , Metaboloma , Estrés Oxidativo , Purinas/metabolismo , Xantina/metabolismo
2.
Ophthalmic Genet ; 38(1): 91-94, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27046515

RESUMEN

The most common cause of isolated inherited homocysteinemia is a deficiency of the enzyme cystathionine ß-synthase (CBS). Clinical manifestations of CBS deficiency can include ectopia lentis, thromboembolism, marfanoid habits, and intellectual disability. CBS deficiency, which affects the transsulfuration pathway, is marked biochemically by elevated serum homocysteine and plasma methionine. We report a patient with homocysteinemia, low plasma methionine, and no significant neurological abnormalities who presented with bilateral subluxated crystalline lenses due to a 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency. MTHFR deficiency, a disorder in the remethylation pathway, can cause mild to severe disease, although most presentations include neurological involvement. MTHFR deficiency has not been previously associated with lens subluxation or complete dislocation. Prolonged exposure to elevated serum homocysteine levels is most likely the explanation for her ectopia lentis. This case expands the differential diagnosis of homocysteinemia and highlights the need for a correct diagnosis to optimize the clinical outcome of patients with this condition.


Asunto(s)
Homocistinuria/complicaciones , Hiperhomocisteinemia/etiología , Subluxación del Cristalino/etiología , Metilenotetrahidrofolato Reductasa (NADPH2)/deficiencia , Espasticidad Muscular/complicaciones , Tetrahidrofolatos/deficiencia , Adulto , Betaína/uso terapéutico , Quimioterapia Combinada , Femenino , Homocisteína/sangre , Homocistinuria/diagnóstico , Homocistinuria/tratamiento farmacológico , Humanos , Hiperhomocisteinemia/diagnóstico , Hiperhomocisteinemia/tratamiento farmacológico , Subluxación del Cristalino/diagnóstico , Leucovorina/uso terapéutico , Lipotrópicos/uso terapéutico , Metionina/sangre , Espasticidad Muscular/diagnóstico , Espasticidad Muscular/tratamiento farmacológico , Polimorfismo de Nucleótido Simple , Trastornos Psicóticos/complicaciones , Trastornos Psicóticos/diagnóstico , Trastornos Psicóticos/tratamiento farmacológico , Tetrahidrofolatos/genética , Complejo Vitamínico B/uso terapéutico
3.
J Org Chem ; 76(19): 8131-7, 2011 Oct 07.
Artículo en Inglés | MEDLINE | ID: mdl-21854041

RESUMEN

2,4-Disubstituted furans are prepared by treating 2,3-dibromo-1-phenylsulfonyl-1-propene (DBP, 2) with 1,3-diketones under basic conditions. The furan-forming step involves a deacetylation, and the selectivity of this process depends upon the steric demand of the R group. The substituent in position 4 is elaborated by reaction of sulfonyl carbanions with alkyl halides, acyl halides, and aldehydes. Oxidative or reductive desulfonylation produces the 2,4-disubstituted furans in 60-92% yield. This strategy has been used to prepare rabdoketone A (12) and the naturally occurring nematotoxic furoic acid 13.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...